Modeling Alveolar Soft Part Sarcomagenesis in the Mouse: A Role for Lactate in the Tumor Microenvironment

Cancer Cell

Volumn 26, Issue 6, 2014, Pages 851-862

  Goodwin, Matthew L ^a   Jin, Huifeng ^a,b   Straessler, Krystal ^a   Smith Fry, Kyllie ^a,b   Zhu, Ju Fen ^a,b   Monument, Michael J ^a,b   Grossmann, Allie ^a   Randall, R Lor ^a,b   Capecchi, Mario R ^a,c   Jones, Kevin B ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; ASPSCR1 PROTEIN, HUMAN; ASPSCR1 PROTEIN, MOUSE; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; CARRIER PROTEIN; ONCOPROTEIN; TCFE3 PROTEIN, MOUSE; TFE3 PROTEIN, HUMAN;

ALVEOLAR SOFT PART SARCOMA; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FUSION GENE; GENE EXPRESSION; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN METABOLISM; SARCOMAGENESIS; SKULL; TUMOR CELL; TUMOR MICROENVIRONMENT; ADOLESCENT; ADULT; ANIMAL; BRAIN; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

MUS;

ADOLESCENT; ADULT; ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BRAIN; CARRIER PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LACTIC ACID; MICE; NEOPLASMS, EXPERIMENTAL; ONCOGENE PROTEINS, FUSION; SARCOMA, ALVEOLAR SOFT PART; TUMOR MICROENVIRONMENT;

EID: 84919480908     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2014.10.003     Document Type: Article

References (63)

1. Agaimy A., Rösch J., Weyand M., Strecker T. Primary and metastatic cardiac sarcomas: a 12-year experience at a German heart center. Int. J. Clin. Exp. Pathol. 2012, 5:928-938.
2. Anders S., Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010, 11:R106.
3. Argani P., Antonescu C.R., Illei P.B., Lui M.Y., Timmons C.F., Newbury R., Reuter V.E., Garvin A.J., Perez-Atayde A.R., Fletcher J.A., et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am. J. Pathol. 2001, 159:179-192.
4. Argani P., Lal P., Hutchinson B., Lui M.Y., Reuter V.E., Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am. J. Surg. Pathol. 2003, 27:750-761.
5. Aubert A., Costalat R., Magistretti P.J., Pellerin L. Brain lactate kinetics: Modeling evidence for neuronal lactate uptake upon activation. Proc. Natl. Acad. Sci. USA 2005, 102:16448-16453.
6. Badea T.C., Wang Y., Nathans J. A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse. J.Neurosci. 2003, 23:2314-2322.
7. Bodi I., Gonzalez D., Epaliyange P., Gullan R., Fisher C. Meningeal alveolar soft part sarcoma confirmed by characteristic ASPCR1-TFE3 fusion. Neuropathology 2009, 29:460-465.
8. Bonuccelli G., Tsirigos A., Whitaker-Menezes D., Pavlides S., Pestell R.G., Chiavarina B., Frank P.G., Flomenberg N., Howell A., Martinez-Outschoorn U.E., et al. Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010, 9:3506-3514.
9. Brizel D.M., Schroeder T., Scher R.L., Walenta S., Clough R.W., Dewhirst M.W., Mueller-Klieser W. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2001, 51:349-353.
10. Brooks G.A. Lactate shuttles in nature. Biochem. Soc. Trans. 2002, 30:258-264.
11. Brooks G.A., Gaesser G.A. End points of lactate and glucose metabolism after exhausting exercise. J.Appl. Physiol. 1980, 49:1057-1069.
12. Burns P.A., Wilson D.J. Angiogenesis mediated by metabolites isdependent on vascular endothelial growth factor (VEGF). Angiogenesis 2003, 6:73-77.
13. Covell D.G., Wallqvist A., Kenney S., Vistica D.T. Bioinformatic analysis of patient-derived ASPS gene expressions and ASPL-TFE3 fusion transcript levels identify potential therapeutic targets. PLoS ONE 2012, 7:e48023.
14. Das K.K., Singh R.K., Jaiswal S., Agrawal V., Jaiswal A.K., Behari S. Alveolar soft part sarcoma of the frontal calvarium and adjacent frontal lobe. J.Pediatr. Neurosci. 2012, 7:36-39.
15. De Saedeleer C.J., Copetti T., Porporato P.E., Verrax J., Feron O., Sonveaux P. Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells. PLoS ONE 2012, 7:e46571.
16. Folpe A.L., Deyrup A.T. Alveolar soft-part sarcoma: a review and update. J.Clin. Pathol. 2006, 59:1127-1132.
17. Fox B.D., Patel A., Suki D., Rao G. Surgical management of metastatic sarcoma to the brain. J.Neurosurg. 2009, 110:181-186.
18. Gertz E.W., Wisneski J.A., Stanley W.C., Neese R.A. Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments. J.Clin. Invest. 1988, 82:2017-2025.
19. Gladden L.B. A lactatic perspective on metabolism. Med. Sci. Sports Exerc. 2008, 40:477-485.
20. Haldar M., Hancock J.D., Coffin C.M., Lessnick S.L., Capecchi M.R. A conditional mouse model of synovial sarcoma: insights into a myogenic origin. Cancer Cell 2007, 11:375-388.
21. Halestrap A.P. The SLC16 gene family - structure, role and regulation in health and disease. Mol. Aspects Med. 2013, 34:337-349.
22. Harris A.L. Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer 2002, 2:38-47.
23. Hasson P., Del Buono J., Logan M.P. Tbx5 is dispensable for forelimb outgrowth. Development 2007, 134:85-92.
24. Helman L.J., Meltzer P. Mechanisms of sarcoma development. Nat. Rev. Cancer 2003, 3:685-694.
25. Ishiguro M., Iwasaki H., Ohjimi Y., Kaneko Y. Establishment and characterization of a renal cell carcinoma cell line (FU-UR-1) with the reciprocal ASPL-TFE3 fusion transcript. Oncol. Rep. 2004, 11:1169-1175.
26. Joshi S.K., Hashimoto K., Koni P.A. Induced DNA recombination by Cre recombinase protein transduction. Genesis 2002, 33:48-54.
27. Kawanami A., Matsushita T., Chan Y.Y., Murakami S. Mice expressingGFP and CreER in osteochondro progenitor cells in the periosteum. Biochem. Biophys. Res. Commun. 2009, 386:477-482.
28. Keller C., Arenkiel B.R., Coffin C.M., El-Bardeesy N., DePinho R.A., Capecchi M.R. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev. 2004, 18:2614-2626.
29. Kenney S., Vistica D.T., Stockwin L.H., Burkett S., Hollingshead M.G., Borgel S.D., Butcher D.O., Schrump D.S., Shoemaker R.H. ASPS-1, a novel cell line manifesting key features of alveolar soft part sarcoma. J.Pediatr. Hematol. Oncol. 2011, 33:360-368.
30. Kobos R., Nagai M., Tsuda M., Merl M.Y., Saito T., Laé M., Mo Q., Olshen A., Lianoglou S., Leslie C., et al. Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein. J.Pathol. 2013, 229:743-754.
31. Kumar V.B., Viji R.I., Kiran M.S., Sudhakaran P.R. Endothelial cell response to lactate: implication of PAR modification of VEGF. J.Cell. Physiol. 2007, 211:477-485.
32. Kumar N., Agarwal S., Ahuja A., Das P., Airon B., Ray R. Spectrum of cardiac tumors excluding myxoma: Experience of a tertiary center with review of the literature. Pathol. Res. Pract. 2011, 207:769-774.
33. Kummar S., Allen D., Monks A., Polley E.C., Hose C.D., Ivy S.P., Turkbey I.B., Lawrence S., Kinders R.J., Choyke P., et al. Cediranib for metastatic alveolar soft part sarcoma. J.Clin. Oncol. 2013, 31:2296-2302.
34. Ladanyi M., Lui M.Y., Antonescu C.R., Krause-Boehm A., Meindl A., Argani P., Healey J.H., Ueda T., Yoshikawa H., Meloni-Ehrig A., et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 2001, 20:48-57.
35. Ladanyi M., Antonescu C.R., Drobnjak M., Baren A., Lui M.Y., Golde D.W., Cordon-Cardo C. The precrystalline cytoplasmic granules ofalveolar soft part sarcoma contain monocarboxylate transporter 1 and CD147. Am. J. Pathol. 2002, 160:1215-1221.
36. Lazar A.J., Das P., Tuvin D., Korchin B., Zhu Q., Jin Z., Warneke C.L., Zhang P.S., Hernandez V., Lopez-Terrada D., et al. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma. Clinical cancer research: an official journal of the American Association for Cancer Research 2007, 13:7314-7321.
37. Li C., Hung Wong W. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol 2001, 2. RESEARCH0032.
38. Logan M., Martin J.F., Nagy A., Lobe C., Olson E.N., Tabin C.J. Expression of Cre Recombinase in the developing mouse limb bud driven by aPrxl enhancer. Genesis 2002, 33:77-80.
39. Lowry O.H., Berger S.J., Carter J.G., Chi M.M., Manchester J.K., Knor J., Pusateri M.E. Diversity of metabolic patterns in human brain tumors: enzymes of energy metabolism and related metabolites and cofactors. J.Neurochem. 1983, 41:994-1010.
40. Lu H., Forbes R.A., Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J.Biol. Chem. 2002, 277:23111-23115.
41. Lu H., Dalgard C.L., Mohyeldin A., McFate T., Tait A.S., Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J.Biol. Chem. 2005, 280:41928-41939.
42. Luo J., Melnick S., Rossi A., Burke R.P., Pfeifer J.D., Dehner L.P. Primary cardiac alveolar soft part sarcoma. A report of the first observed case with molecular diagnostics corroboration. Pediatr. Dev. Pathol. 2008, 11:142-147.
43. Mao X., Fujiwara Y., Orkin S.H. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc. Natl. Acad. Sci. USA 1999, 96:5037-5042.
44. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstråle M., Laurila E., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34:267-273.
45. Nix D.A., Courdy S.J., Boucher K.M. Empirical methods for controlling false positives and estimating confidence in ChIP-Seq peaks. BMC Bioinformatics 2008, 9:523.
46. Pagliarini D.J., Calvo S.E., Chang B., Sheth S.A., Vafai S.B., Ong S.E., Walford G.A., Sugiana C., Boneh A., Chen W.K., et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008, 134:112-123.
47. Pérez-Losada J., Pintado B., Gutiérrez-Adán A., Flores T., Bañares-González B., del Campo J.C., Martín-Martín J.F., Battaner E., Sánchez-García I. The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene 2000, 19:2413-2422.
48. Rosenberger C., Rosen S., Paliege A., Heyman S.N. Pimonidazole adduct immunohistochemistry in the rat kidney: detection of tissue hypoxia. Methods Mol. Biol. 2009, 466:161-174.
49. Semenza G.L. Tumor metabolism: cancer cells give and take lactate. J.Clin. Invest. 2008, 118:3835-3837.
50. Semenza G.L. Hypoxia-inducible factors in physiology and medicine. Cell 2012, 148:399-408.
51. Shimozaki K., Clemenson G.D., Gage F.H. Paired related homeobox protein 1 is a regulator of stemness in adult neural stem/progenitor cells. J.Neurosci. 2013, 33:4066-4075.
52. Smetana H.F., Scott W.F. Malignant tumors of nonchromaffin paraganglia. Mil. Surg. 1951, 109:330-349.
53. Sonveaux P., Végran F., Schroeder T., Wergin M.C., Verrax J., Rabbani Z.N., De Saedeleer C.J., Kennedy K.M., Diepart C., Jordan B.F., et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J.Clin. Invest. 2008, 118:3930-3942.
54. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 1999, 21:70-71.
55. Stanley W.C. Myocardial lactate metabolism during exercise. Med. Sci. Sports Exerc. 1991, 23:920-924.
56. Stockwin L.H., Vistica D.T., Kenney S., Schrump D.S., Butcher D.O., Raffeld M., Shoemaker R.H. Gene expression profiling of alveolar soft-part sarcoma (ASPS). BMC Cancer 2009, 9:22.
57. Straessler K.M., Jones K.B., Hu H., Jin H., van de Rijn M., Capecchi M.R. Modeling clear cell sarcomagenesis in the mouse: cell of origin differentiation state impacts tumor characteristics. Cancer Cell 2013, 23:215-227.
58. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102:15545-15550.
59. Vistica D.T., Hollingshead M., Borgel S.D., Kenney S., Stockwin L.H., Raffeld M., Schrump D.S., Burkett S., Stone G., Butcher D.O., Shoemaker R.H. Therapeutic vulnerability of an invivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy. J.Pediatr. Hematol. Oncol. 2009, 31:561-570.
60. Walenta S., Salameh A., Lyng H., Evensen J.F., Mitze M., Rofstad E.K., Mueller-Klieser W. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am. J. Pathol. 1997, 150:409-415.
61. Walenta S., Schroeder T., Mueller-Klieser W. Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr. Med. Chem. 2004, 11:2195-2204.
62. Xiong M., Elson G., Legarda D., Leibovich S.J. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am. J. Pathol. 1998, 153:587-598.
63. Zambon A.C., Gaj S., Ho I., Hanspers K., Vranizan K., Evelo C.T., Conklin B.R., Pico A.R., Salomonis N. GO-Elite: a flexible solution for pathway and ontology over-representation. Bioinformatics 2012, 28:2209-2210.